3rd dose helps against Omicron: AstraZeneca

London, January 13 AstraZeneca said on Thursday that preliminary data from a trial showed that its Covid-19 shot, Vaxzevria, generated an increase in antibodies against Omicron and other variants when given as a third booster dose. The increased response, also...

Tribune Web Desk

Updated At : 02:16 PM Jan 14, 2022 IST

London, January 13

AstraZeneca said on Thursday that preliminary data from a trial showed that its Covid-19 shot, Vaxzevria, generated an increase in antibodies against Omicron and other variants when given as a third booster dose.

The increased response, also against the Delta variant, was seen in a blood analysis of people who were previously vaccinated with either Vaxzevria or an mRNA vaccine, the drugmaker said, adding it would submit this data to regulators worldwide given the urgent need for boosters. Lab studies conducted by the university last month already found a three-dose course of Vaxzevria boosted antibody levels in the blood against the rapidly spreading Omicron variant. — Reuters

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Suggested Articles